Table 2.

Univariate analysis of the influence of clinical parameters on OS in MM patients (P<0.05).

Characteristics		n	OS, %	P-value
Sex	Male	67	62.7	0.805
	Female	35	65.7
Age, y	<60	49	71.4	0.083
	≥60	53	56.6
BMI, kg/m2	<22.85	42	66.7	0.335
	≥22.85	44	75.0
DS staging	Stage I	7	85.7	0.138
	Stage II	15	66.7
	Stage III	80	61.3
	Group A	74	67.6	0.054
	Group B	28	53.6
ISS staging	Stage I	5	100	0.088
	Stage II	36	71.9
	Stage III	61	60.7
ISS dichotomy	Early stage	41	75.7	0.04
	Late stage	61	60.7
L-ISS staging	Stage I	5	80	0.004
	Stage II	56	75
	Stage III	41	46.3
L-ISS dichotomy	Early stage	61	78	<0.001
	Late stage	41	48.7
M-fraction type	IgG	49	75.5	0.004
	IgA	20	65
	Light chain	26	46.2
Light chain type	κ	55	60	0.519
	λ	43	72.1
ALC	<1.43×109/L	51	52.9	0.045
	≥1.43×109/L	51	74.5
AMC	<0.4×109/L	52	67.3	0.284
	≥0.4×109/L	50	60.0
LMR	<3.7	50	50.0	<0.001
	≥3.7	52	76.9
HGB, g/L	<100	71	60.6	0.142
	≥100	31	71.0
PLT	<135×109/L	36	61.1	0.381
	≥135×109/L	66	65.2
LDH, U/L	<243	60	58.3	0.914
	≥243	42	60.0
β2-MG dichotomy, mg/L	<5.5	36	77.8	0.053
	≥5.5	61	60.7
ALB, g/L	<35	64	69.8	0.039
	≥35	38	55.3
Ca, mmol/L	<2.75	90	64.4	0.545
	≥2.75	12	58.3
IgG dichotomy, g/L	<70	31	80.6	0.362
	≥70	16	68.8
IgA dichotomy, g/L	<50	13	76.9	0.109
	≥50	7	42.9